Content area

Details

Title
540; HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis
Author
Brinson, Cynthia 1 ; Lalezari, Jacob 2 ; Latiff, Gulam H 3 ; Thompson, Melanie 4 ; Echevarría, Juan 5 ; Treviño-Pérez, Sandra 6 ; Stock, David 7 ; Joshi, Samit R 7 ; Hanna, George J 8 ; Lataillade, Max 7 

1  Central Texas Clinical Research, Austin, TX; Central Texas Clinical Research, Austin, TX 
2  Quest Clinical Research, San Francisco, CA; Central Texas Clinical Research, Austin, TX 
3  Maxwell Clinic, Durban, South Africa; Central Texas Clinical Research, Austin, TX 
4  AIDS Research Consortium of Atlanta, Atlanta, GA; Central Texas Clinical Research, Austin, TX 
5  Hospital Nacional Cayetano Heredia, Lima, Peru; Central Texas Clinical Research, Austin, TX 
6  Mexico Centre for Clinical Research, Mexico City, Mexico; Central Texas Clinical Research, Austin, TX 
7  Bristol-Myers Squibb, Wallingford, CT; Central Texas Clinical Research, Austin, TX 
8  Bristol-Myers Squibb, Princeton, NJ; Central Texas Clinical Research, Austin, TX 
Pages
S22-S23
Publication year
2014
Publication date
Fall 2014
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/ofid/ofu051.59
ProQuest document ID
3170984162
Copyright
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.